Streetbeat News

Products Services

MRVI

TriLink BioTechnologies is expanding its manufacturing capabilities with a new 32,000-square-foot, cGMP-grade facility nearing completion. This will boost the company's mRNA manufacturing capacity.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:19 pm

QNRX

Quoin Pharmaceuticals has announced 50% enrollment in its open-label clinical trial for Netherton Syndrome, a rare genetic skin disorder.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:18 pm

ALIM

Alimera Sciences has completed enrollment for its NEW DAY clinical trial, a study designed to generate data for ILUVIEN, a baseline therapy for patients diagnosed with diabetic macular edema (DME).

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:17 pm

MNDY

MSFT

monday.com has announced the integration of its monday sales CRM with Microsoft Teams, allowing users to access and edit their pipeline and data in one place. The integration aims to increase customer-facing teams' efficiency and productivity.

Portfolio Pulse from Happy Mohamed

May 24, 2023 | 12:17 pm

PTCT

PTC Therapeutics announced that its MOVE-FA trial of vatiquinone failed to meet its primary endpoint, leading to a decline in its share price. The company will also discontinue its preclinical and early research gene therapy programs.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:15 pm

NFLX

Netflix shares dropped after the company provided an update on its password-sharing crackdown, with options traders betting on the stock moving lower. The company will email customers sharing Netflix outside their household in the US.

Portfolio Pulse from Priya Nigam

May 24, 2023 | 12:14 pm

GOVX

GeoVax has provided an update on the development of its next-generation SARS-CoV-2 vaccine, GEO-CM04S1. The company is making progress in preclinical studies and is preparing for clinical trials.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:08 pm

WKSP

Worksport's hard-folding truck cover samples have been approved for production by a national U.S. automotive aftermarket reseller. This approval is expected to boost Worksport's (WKSP) sales and market presence.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:07 pm

FDMT

4D Molecular Therapeutics (4DMT) will present interim data from its 4D-710 Phase 1/2 AEROW clinical trial for cystic fibrosis lung disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting on June 8.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 12:03 pm